Derrick Rossi

Biotech company Moderna, co-founded by HSCI scientist Derrick Rossi, is set to bring a new class of treatments to patients. Summary Derrick Rossi’s research into using mRNA as a new kind of therapeutic was initially supported by HSCI seed funding, and...

Startup Magenta Therapeutics licences technologies from Harvard, MGH, and Boston Children's that could transform treatment of blood diseases and immune disorders Harvard University has completed a license agreement with Magenta Therapeutics, a new startup...

A possible new approach to treating HIV/AIDS Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General (MGH) and Boston Children’s hospitals for the first time have used a relatively new gene-editing technique to create what could prove to...

Discovery opens new possibilities for regenerative medicine Harvard Stem Cell Institute researchers at Boston Children’s Hospital have reprogrammed mature blood cells from mice into blood-forming hematopoietic stem cells (HSCs) using a cocktail of eight...

This week the New York Times published an article announcing a $240M investment by Astra Zeneca in Moderna Therapeutics, a start-up company founded by HSCI Principal Faculty Derrick Rossi. As the Times says, "It is one of the largest ever initial payments...

Heart attacks cause the death of billions of the heart’s muscle cells. If these cardiomyocytes could be made to regenerate after an infarct, the heart could potentially be mended and its function restored. Researchers have struggled to find the right...